Safe and Effective Drug Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Safe and Effective Drug Act - Requires the Director of the National Institutes of Health (NIH), acting through the Director of the National Institute on Drug Abuse, to develop a meta-analysis and report to Congress on the scientific data regarding the safety and health risks of smoking marijuana and the clinically-proven effectiveness of smoking marijuana for medicinal purposes. Requires the Commissioner of Food and Drugs to: (1) post such report on the Internet site of the Food and Drug Administration not later than 30 days after receipt; and (2) promptly disseminate such report to principal public health agencies of all States, and to public health associations, health care professionals, and other appropriate entities that advocate or recommend the smoking of marijuana by patients for medicinal purposes.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5429: Safe and Effective Drug Act. 108th Congress. Open America. https://openamerica.io/bill/108-HR-5429/
"H.R. 5429: Safe and Effective Drug Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-5429/.
H.R. 5429, 108th Cong. (2026), https://openamerica.io/bill/108-HR-5429/.
[H.R. 5429: Safe and Effective Drug Act](https://openamerica.io/bill/108-HR-5429/)